$33.99
-0.48-1.39%
Last update: Nov 10, 4:38 PM
Pharvaris NV
PHVSNASDAQ
Pharvaris rose 52.3% from $22.63 to $34.47, ahead of the S&P 500's +10.0%. Its worst day was Apr 23 (−9.2%), and its low came Nov 10 at $22.63.
Nov 10, 2025 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-0.70 beat the $-0.78 estimate on $0.00 revenue.
+7.0% · S&P 500 +0.1%
Pharvaris shares rose 8.9%, while the S&P 500 rose 0.7%.
Story events cover the past 12 months · Times ET
+8.9%, the year's best day · S&P 500 +0.7%
EPS of $-0.84 missed the $-0.69 estimate on $0.00 revenue.
−3.0% · S&P 500 +0.1%
Pharvaris shares fell 9.2%, while the S&P 500 fell 0.4%.
−9.2%, the year's worst day · S&P 500 −0.4%
EPS of $-0.69 beat the $-0.77 estimate on $0.00 revenue.
+5.4% · S&P 500 +0.6%
EPS of $-0.81 missed the $-0.74 estimate on $0.00 revenue.
+5.9% · S&P 500 +0.3%
Pharvaris closed at its highest level of the year, 71.7% above where the year started.
+2.2% · S&P 500 −0.4%
Where it ended: a close of $34.47 on Nov 9, 2026. Up next: Q3 2026 earnings on Nov 24, 2026 (EPS est. $-0.82).
Nothing in the past 12 months.
All PHVS dividend historyReplay the year: the line draws itself and stops at each of the 7 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for PHVS and SPY from Benzinga historical bars. Not investment advice.
